Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

Lower glycemic indices and lipid profile among type 2 diabetes mellitus patients who received novel dose of Silybum marianum (L.) Gaertn. (silymarin) extract supplement: A Triple-blinded randomized controlled clinical trial.

Ebrahimpour-Koujan S, Gargari BP, Mobasseri M, Valizadeh H, Asghari-Jafarabadi M.

Phytomedicine. 2018 May 15;44:39-44. doi: 10.1016/j.phymed.2018.03.050. Epub 2018 Mar 19.

PMID:
29895491
2.

Relative Bioavailability of Silybin A and Silybin B From 2 Multiconstituent Dietary Supplement Formulations Containing Milk Thistle Extract: A Single-dose Study.

Li WY, Yu G, Hogan RM, Mohandas R, Frye RF, Gumpricht E, Markowitz JS.

Clin Ther. 2018 Jan;40(1):103-113.e1. doi: 10.1016/j.clinthera.2017.11.013. Epub 2017 Dec 19.

3.

Semen quality, antioxidant status and reproductive performance of rabbits bucks fed milk thistle seeds and rosemary leaves.

Attia YA, Hamed RS, Bovera F, Abd El-Hamid AEE, Al-Harthi MA, Shahba HA.

Anim Reprod Sci. 2017 Sep;184:178-186. doi: 10.1016/j.anireprosci.2017.07.014. Epub 2017 Jul 23.

PMID:
28765034
4.

Bioimpedance analysis, metabolic effects and safety of the association Berberis aristata/Bilybum marianum: a 52-week double-blind, placebo-controlled study in obese patients with type 2 diabetes.

Guarino G, Strollo F, Carbone L, Della Corte T, Letizia M, Marino G, Gentile S.

J Biol Regul Homeost Agents. 2017 Apr-Jun;31(2):495-502.

PMID:
28685558
5.

Topical Silymarin Administration for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.

Elyasi S, Shojaee FSR, Allahyari A, Karimi G.

Phytother Res. 2017 Sep;31(9):1323-1329. doi: 10.1002/ptr.5857. Epub 2017 Jun 21.

PMID:
28635153
6.

Effects of milk thistle meal on performance, ileal bacterial enumeration, jejunal morphology and blood lipid peroxidation in laying hens fed diets with different levels of metabolizable energy.

Hashemi Jabali NS, Mahdavi AH, Ansari Mahyari S, Sedghi M, Akbari Moghaddam Kakhki R.

J Anim Physiol Anim Nutr (Berl). 2018 Apr;102(2):410-420. doi: 10.1111/jpn.12747. Epub 2017 Jun 13.

PMID:
28608581
7.

Effect of Oral Silymarin Administration on Prevention of Radiotherapy Induced Mucositis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.

Elyasi S, Hosseini S, Niazi Moghadam MR, Aledavood SA, Karimi G.

Phytother Res. 2016 Nov;30(11):1879-1885. doi: 10.1002/ptr.5704. Epub 2016 Aug 23.

PMID:
27555604
8.

The role of a fixed Berberis aristata/Silybum marianum combination in the treatment of type 1 diabetes mellitus.

Derosa G, D'Angelo A, Maffioli P.

Clin Nutr. 2016 Oct;35(5):1091-5. doi: 10.1016/j.clnu.2015.08.004. Epub 2015 Sep 2.

PMID:
26384091
9.

Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trial.

Zhang S, Pan H, Peng X, Lu H, Fan H, Zheng X, Xu G, Wang M, Wang J.

J Gastroenterol Hepatol. 2016 Feb;31(2):409-16. doi: 10.1111/jgh.13070.

PMID:
26243373
10.

Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial.

Ebrahimpour Koujan S, Gargari BP, Mobasseri M, Valizadeh H, Asghari-Jafarabadi M.

Phytomedicine. 2015 Feb 15;22(2):290-6. doi: 10.1016/j.phymed.2014.12.010. Epub 2015 Jan 19.

PMID:
25765835
11.

Berberis aristata/Silybum marianum fixed combination (Berberol(®)) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: a randomized, placebo-controlled, clinical trial.

Derosa G, Romano D, D'Angelo A, Maffioli P.

Phytomedicine. 2015 Feb 15;22(2):231-7. doi: 10.1016/j.phymed.2014.11.018. Epub 2014 Dec 18.

PMID:
25765827
12.

Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses.

Derosa G, Romano D, D'Angelo A, Maffioli P.

Atherosclerosis. 2015 Mar;239(1):87-92. doi: 10.1016/j.atherosclerosis.2014.12.043. Epub 2014 Dec 24.

PMID:
25577665
13.

The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity.

Kawaguchi-Suzuki M, Frye RF, Zhu HJ, Brinda BJ, Chavin KD, Bernstein HJ, Markowitz JS.

Drug Metab Dispos. 2014 Oct;42(10):1611-6. doi: 10.1124/dmd.114.057232. Epub 2014 Jul 15.

14.

A randomized, placebo-controlled study on the effects of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters.

Derosa G, Bonaventura A, Bianchi L, Romano D, D'Angelo A, Fogari E, Maffioli P.

J Biol Regul Homeost Agents. 2014 Apr-Jun;28(2):317-24.

PMID:
25001663
15.

Effects of Berberis aristata/Silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients.

Derosa G, Bonaventura A, Bianchi L, Romano D, D' Angelo A, Fogari E, Maffioli P.

J Biol Regul Homeost Agents. 2013 Jul-Sep;27(3):717-28.

PMID:
24152839
16.

Evaluation of antioxidant capacity and inflammatory cytokine gene expression in horses fed silibinin complexed with phospholipid.

Hackett ES, Mama KR, Twedt DC, Gustafson DL.

Am J Vet Res. 2013 Oct;74(10):1333-9. doi: 10.2460/ajvr.74.10.1333.

PMID:
24066918
17.

Pharmacokinetics and safety of silibinin in horses.

Hackett ES, Mama KR, Twedt DC, Gustafson DL.

Am J Vet Res. 2013 Oct;74(10):1327-32. doi: 10.2460/ajvr.74.10.1327.

PMID:
24066917
18.

Use of selenium-silymarin mix reduces lower urinary tract symptoms and prostate specific antigen in men.

Vostalova J, Vidlar A, Ulrichova J, Vrbkova J, Simanek V, Student V.

Phytomedicine. 2013 Dec 15;21(1):75-81. doi: 10.1016/j.phymed.2013.07.018. Epub 2013 Sep 5.

PMID:
24012146
19.

Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients.

Derosa G, Bonaventura A, Bianchi L, Romano D, D'Angelo A, Fogari E, Maffioli P.

Expert Opin Biol Ther. 2013 Nov;13(11):1495-506. doi: 10.1517/14712598.2013.832751. Epub 2013 Aug 24.

PMID:
23971720
20.

A phase I dose-finding study of silybin phosphatidylcholine (milk thistle) in patients with advanced hepatocellular carcinoma.

Siegel AB, Narayan R, Rodriguez R, Goyal A, Jacobson JS, Kelly K, Ladas E, Lunghofer PJ, Hansen RJ, Gustafson DL, Flaig TW, Tsai WY, Wu DP, Lee V, Greenlee H.

Integr Cancer Ther. 2014 Jan;13(1):46-53. doi: 10.1177/1534735413490798. Epub 2013 Jun 11.

Supplemental Content

Loading ...
Support Center